John Engels Latest Insider Activity
Management EfficiencyThe company has return on total asset (ROA) of (8.06) % which means that it has lost $8.06 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (21.86) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryAxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 184 people.AxoGen (AXGN) is traded on BATS Exchange in USA. It is located in FLORIDA U.S.A and employs 184 people. AxoGen is listed under Medical Equipment category by Fama And French industry classification.
AxoGen Leadership Team
Stock Performance Indicators